Cargando…
Cortical Binding Potential of Opioid Receptors in Patients With Fibromyalgia Syndrome and Reduced Systemic Interleukin-4 Levels – A Pilot Study
Objective: We investigated cerebral opioid receptor binding potential in patients with fibromyalgia syndrome (FMS) using positron-emission-tomography (PET) and correlated our results with patients’ systemic interleukin-4 (IL-4) gene expression. Methods: In this pilot study, seven FMS patients (1 man...
Autores principales: | Üçeyler, Nurcan, Buchholz, Hans-Georg, Kewenig, Susanne, Ament, Stephan-Johann, Birklein, Frank, Schreckenberger, Mathias, Sommer, Claudia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248364/ https://www.ncbi.nlm.nih.gov/pubmed/32508586 http://dx.doi.org/10.3389/fnins.2020.00512 |
Ejemplares similares
-
Increased cortical activation upon painful stimulation in fibromyalgia syndrome
por: Üçeyler, Nurcan, et al.
Publicado: (2015) -
Skin cytokine expression in patients with fibromyalgia syndrome is not different from controls
por: Üçeyler, Nurcan, et al.
Publicado: (2014) -
Systematic review with meta-analysis: cytokines in fibromyalgia syndrome
por: Üçeyler, Nurcan, et al.
Publicado: (2011) -
Characterization of dermal skin innervation in fibromyalgia syndrome
por: Evdokimov, Dimitar, et al.
Publicado: (2020) -
New treatment options for fibromyalgia: critical appraisal of duloxetine
por: Üçeyler, Nurcan, et al.
Publicado: (2008)